Cushing's Disease: Assessment of Early Cardiovascular Hemodynamic Dysfunction With Impedance Cardiography

Agnieszka Jurek1, Paweł Krzesiński1, Grzegorz Gielerak1

  • 1Department of Cardiology and Internal Diseases, Military Institute of Medicine, Warsaw, Poland.

Insights

Cushing's disease patients exhibit impaired hemodynamics, including reduced cardiac output and increased vascular resistance, detectable by impedance cardiography. This noninvasive method aids in identifying cardiovascular complications for targeted treatment.

Area of Science:

  • Cardiology
  • Endocrinology
  • Medical Technology

Background:

  • Cushing's disease presents a high cardiovascular risk due to hypercortisolemia, leading to hemodynamic dysfunction.
  • Standard hemodynamic assessments may be insufficient for Cushing's disease patients.
  • Impedance cardiography offers a noninvasive method for assessing early hemodynamic dysfunction.

Purpose of the Study:

  • To assess the hemodynamic profile of Cushing's disease patients.
  • To compare the hemodynamic profile of Cushing's disease patients with a control group.
  • To explore impedance cardiography's utility in understanding Cushing's disease pathophysiology.

Main Methods:

  • An observational prospective clinical study comparing 54 Cushing's disease patients with 54 matched controls.
  • Assessment of hemodynamic parameters including stroke index (SI), cardiac index (CI), and systemic vascular resistance index (SVRI) using impedance cardiography.
  • Inclusion of parameters like velocity index (VI), acceleration index (ACI), Heather index (HI), and thoracic fluid content (TFC).

Main Results:

  • Cushing's disease patients had higher diastolic blood pressure and were younger than controls.
  • Significantly lower SI, CI, VI, ACI, HI, and TFC were observed in Cushing's disease patients.
  • Cushing's disease patients exhibited significantly higher SVRI, indicating increased vasoconstriction.

Conclusions:

  • Cushing's disease is linked to increased vasoconstriction and left ventricular systolic dysfunction.
  • Impedance cardiography can identify subclinical cardiovascular complications in Cushing's disease.
  • Individualized impedance cardiography assessment may guide therapeutic targets for chronic hypercortisolemia complications.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
94
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
532
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
74
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
559
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
578
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
519